These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 30910901

  • 1. In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates.
    Narayanaswamy VP, Duncan AP, LiPuma JJ, Wiesmann WP, Baker SM, Townsend SM.
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910901
    [Abstract] [Full Text] [Related]

  • 2. Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.
    Narayanaswamy VP, Giatpaiboon S, Baker SM, Wiesmann WP, LiPuma JJ, Townsend SM.
    PLoS One; 2017 Jun; 12(6):e0179776. PubMed ID: 28662114
    [Abstract] [Full Text] [Related]

  • 3. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
    Kennedy S, Beaudoin T, Yau YC, Caraher E, Zlosnik JE, Speert DP, LiPuma JJ, Tullis E, Waters V.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
    [Abstract] [Full Text] [Related]

  • 4. Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapy.
    Aiyer A, Manoharan A, Paino D, Farrell J, Whiteley GS, Kriel FH, Glasbey TO, Manos J, Das T.
    Int J Antimicrob Agents; 2021 Aug; 58(2):106372. PubMed ID: 34116184
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms.
    Caraher EM, Gumulapurapu K, Taggart CC, Murphy P, McClean S, Callaghan M.
    J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284
    [Abstract] [Full Text] [Related]

  • 7. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
    Ratjen A, Yau Y, Wettlaufer J, Matukas L, Zlosnik JE, Speert DP, LiPuma JJ, Tullis E, Waters V.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.
    Fraser-Pitt D, Mercer D, Lovie E, Robertson J, O'Neil D.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6200-6. PubMed ID: 27503654
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin.
    Messiaen AS, Nelis H, Coenye T.
    J Cyst Fibros; 2014 Jan; 13(1):56-62. PubMed ID: 23932109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans.
    Caraher E, Duff C, Mullen T, Mc Keon S, Murphy P, Callaghan M, McClean S.
    J Cyst Fibros; 2007 Jan; 6(1):49-56. PubMed ID: 16781896
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.